Consensus statements for management of Barrett's dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process. - Test2 - elhamkhani - TriplyDB

Consensus statements for management of Barrett's dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process.

Consensus statements for management of Barrett's dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process.

http://www.wikidata.org/entity/Q38005810

about

Surgery versus radical endotherapies for early cancer and high-grade dysplasia in Barrett's oesophagus Update on management of Barrett's esophagus Barrett's esophagus in 2016: From pathophysiology to treatment Post-ablation surveillance in Barrett's esophagus: A review of the literature Advances in the management of Barrett's esophagus and early esophageal adenocarcinoma Treatment of esophagogastric junction carcinoma: an unsolved debate Recent developments in esophageal adenocarcinoma Advanced imaging technologies for the detection of dysplasia and early cancer in barrett esophagus.In vivo endomicroscopy improves detection of Barrett's esophagus-related neoplasia: a multicenter international randomized controlled trial (with video).Using the modified Delphi method to establish clinical consensus for the diagnosis and treatment of patients with rotator cuff pathology.BOB CAT: A Large-Scale Review and Delphi Consensus for Management of Barrett's Esophagus With No Dysplasia, Indefinite for, or Low-Grade Dysplasia.Barrett's esophagus: lessons from recent clinical trials Etiology and Prevention of Esophageal Cancer Endoscopic risk factors for neoplastic progression in patients with Barrett's oesophagus Monitoring the premalignant potential of Barrett's oesophagus'.Performance measures for upper gastrointestinal endoscopy: A European Society of Gastrointestinal Endoscopy quality improvement initiative.Adherence to therapy for Barrett's esophagus-associated neoplasia Comparison of endoscopic therapies and surgical resection in patients with early esophageal cancer: a population-based study Intratumoral lactate metabolism in Barrett's esophagus and adenocarcinoma.Low grade dysplasia in Barrett's esophagus: Should we worry?Multispecialty Rating of Evidence-Based Conditions for Intravenous Immunoglobulin Therapy Using a 3-Axis Prioritization Algorithm.Barrett's esophagus and cancer risk: how research advances can impact clinical practice.Endoscopic assessment and management of early esophageal adenocarcinoma Common variants at the MHC locus and at chromosome 16q24.1 predispose to Barrett's esophagus.Barrett's oesophagus: epidemiology, cancer risk and implications for management.British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus.Strategies to improve outcomes in esophageal adenocarcinoma.Screening for Barrett's esophagus and esophageal adenocarcinoma: rationale, recent progress, challenges, and future directions.The combination of autofluorescence endoscopy and molecular biomarkers is a novel diagnostic tool for dysplasia in Barrett's oesophagus.Treatment of dysplastic Barrett's Oesophagus in lower volume centres after structured training.Photodynamic therapy vs radiofrequency ablation for Barrett's dysplasia: efficacy, safety and cost-comparison.Polymorphisms near TBX5 and GDF7 are associated with increased risk for Barrett's esophagus.Evidence-based endoscopic management of Barrett's esophagus Amniotic membrane grafts for the prevention of esophageal stricture after circumferential endoscopic submucosal dissection.Clinical Efficacy of Endoscopic Submucosal Dissection for Adenocarcinomas of the Esophagogastric Junction Improvement over time in outcomes for patients undergoing endoscopic therapy for Barrett's oesophagus-related neoplasia: 6-year experience from the first 500 patients treated in the UK patient registry Radiofrequency Ablation Is Associated With Decreased Neoplastic Progression in Patients With Barrett's Esophagus and Confirmed Low-Grade Dysplasia Laser Imaging Facilitates Early Detection of Synchronous Adenocarcinomas in Patients with Barrett's Esophagus Diagnosis by Endoscopy and Advanced Imaging of Barrett's Neoplasia.New Consensus on the Management of Barrett's Dysplasia and Early Stage Esophageal Adenocarcinoma: Limited Evidence, but Best Available Guidance (Gastroenterology 2012;143:336-346).

P2860

Q24202793-DE81D538-2CE0-4F6C-BBEC-0517DEEB584C Q26751160-2D5DA055-190C-43A9-93F5-25B591107502 Q26751171-4A1343AD-8A15-4CBB-A070-84AD14BABEBD Q26751330-D920D93C-F129-40A7-BAD7-6BD09CD7F6ED Q26781194-63A9C9B1-9780-4221-AC3E-1B65977A3229 Q26827179-414733FA-A6CF-40C9-8974-7BFED8484AB1 Q26849652-49F26871-C141-436B-BBE5-3D2F7838348A Q27003413-F4B0A64B-982F-4607-AD3B-DFA361C4A8F8 Q27311238-EC860D1D-73A4-45AE-A475-752C1FE47802 Q27314728-85115A77-DB73-4438-9616-E0ACECC8120F Q27332349-7EA4F5B8-F4C4-49F5-B3FC-1C61AA59082B Q28077141-30A2756F-3F26-43BD-863E-07D887C54382 Q28077495-9748785B-ABFE-47CA-8BAE-AF19F00B8707 Q28079946-ADC5AC11-934A-434D-AF84-8626F1D8C642 Q28080195-BF958F02-B487-48A9-B9C2-D80301EE5B84 Q28080253-5245B18D-ECF7-4D86-8EAB-70E01CEE9F06 Q30489067-060774E5-90D3-44FC-B9BD-CD20AEA29971 Q30579739-98D675BD-CBE3-41C1-AEDD-65CADC79408D Q33618507-4D4D2642-37E7-45B2-8A7C-9B68EE893190 Q33628118-39202238-4E10-4920-9E98-5E8C958E81F4 Q33795940-75EBF686-EF29-4ED3-89BE-F72B50F95098 Q33959620-EEA50D6D-B48C-4675-A3D7-71BA1253D5B0 Q34049117-4D676855-242A-4A5D-B80E-BEBB0F8D5C45 Q34298428-C03CE9B6-59CC-43C0-B7C0-01E89BFC9681 Q34375216-48515EB0-8A79-439A-BC7C-6AB67C4BD687 Q34380645-C87546C9-A839-4965-8B8F-CF39CEEEC1F2 Q34409666-148BF784-BE4F-4814-A5F1-3593214FDF0F Q34624586-E29B0CA2-FEF1-40C8-8C70-A0AF62FAB553 Q34818554-3D71BA82-B9FF-493C-9211-69DA37BABECC Q34966766-DEC948B3-997E-46B5-B155-DDA8B75374E2 Q35040026-C3493567-850E-4092-96C1-7E9D42355FE2 Q35042479-871B3B96-C2D2-4BD1-8518-DBFAD81E0C67 Q35074266-A987DC79-40B2-4B0D-98DF-F3733B4193FD Q35200736-AED5006A-060B-4F51-8970-E168BCC211E6 Q35579540-4014310E-8203-4232-9609-A5C56A586A03 Q35891829-380BC540-BA9C-402C-B560-82927ABC80E4 Q35998193-58B4F19A-A222-4C08-B17C-AE597715B0EF Q36011803-C1A51681-656B-45DE-A998-7738C7264579 Q36116460-33730331-9008-4CCE-91EC-8671B9D80591 Q36341738-9856F17D-3AAA-4ED7-8EAE-A054981DAB0B

P2860

Consensus statements for management of Barrett's dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process.

http://www.wikidata.org/entity/Q38005810

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Consensus statements for manag ...... ma, based on a Delphi process.

@en

Consensus statements for manag ...... ma, based on a Delphi process.

@en-gb

type

label

Consensus statements for manag ...... ma, based on a Delphi process.

@en

Consensus statements for manag ...... ma, based on a Delphi process.

@en-gb

prefLabel

Consensus statements for manag ...... ma, based on a Delphi process.

@en

Consensus statements for manag ...... ma, based on a Delphi process.

@en-gb

P1433

Q38005810-9274C87A-7158-47AB-9C6A-CFC8CCCBE1B6

P1476

Q38005810-0326F99D-2C2B-456E-BF21-FBBB62C792A8

P2093

Q38005810-045E3B12-1572-4B3C-8662-9650F7E857A5

Q38005810-057F710E-2685-4D8B-8922-40FFC3882942

Q38005810-061E646E-E32F-4988-8F92-F4B654E8C5E4

Q38005810-085CDAC2-AF17-4166-B86E-69D8627468E8

Q38005810-0AE7D8DC-EB76-4F5B-A5F2-7AF000EB3B0F

Q38005810-0C8E214E-ED63-47E6-B622-4FC8EB6CF460

Q38005810-0D251797-7D62-46D2-BE87-763458579A12

Q38005810-12F5E9FA-42C9-4485-87E3-05498F6DC355

Q38005810-155AB468-1BEA-47D6-A139-2A16E52377EC

Q38005810-183573AD-222D-4B30-9545-82EFD61C8448

P2860

Q38005810-015681F5-EF6C-41EF-94B0-5C6E7C5DDA99

Q38005810-018DC9F1-6188-4C90-8871-0A3C5B4299E0

Q38005810-058037D2-99BE-41EE-822D-B6FFE0A72B7C

Q38005810-08C04252-FAD5-447B-84B2-641ABA0CF860

Q38005810-0B0E8C88-E1CF-4B14-A9AD-20858FD8B564

Q38005810-0D15CC05-7D7B-46B9-A6D5-E1C5829E8BB0

Q38005810-114CA841-1BD2-4D1B-A987-31488AACFEF4

Q38005810-15F26BD9-FC62-4BC2-8376-492A7802E185

Q38005810-19277A4C-840E-469D-8361-0C92B4E64A80

Q38005810-19421B0F-9318-419E-974D-B1B1D61F9B87

P304

Q38005810-752BBA2D-83EA-47CE-A951-5C03C0DA1F0F

P31

Q38005810-DA0E2C37-E633-40E2-9357-C7ED98881D1F

P356

Q38005810-DAECE423-D718-4CD6-B80F-D568AC740462

P407

Q38005810-7447B885-BE45-496F-9C7D-CB3791887022

P433

Q38005810-6F3A2515-A633-4F28-9129-AFA9A005CF8C

P478

Q38005810-902323CB-13DA-47A8-9904-53549B8576F4

P50

Q38005810-0B0447BC-DD98-439A-B733-E8E8A5D59B0F

Q38005810-1CD5A300-1A50-4AF6-950D-E7BCB0BA46B7

Q38005810-3CE3E426-5483-413B-A6BF-E14FC7D0C3BE

Q38005810-3EF66980-747B-46B5-A514-767EEF19807A

Q38005810-4C84B993-19C6-42C2-80BE-E208574FC750

Q38005810-571D7CC0-893D-4620-B76F-2F41AA46EB02

Q38005810-74190C05-97E4-4097-A4BC-C3C8CD15D254

Q38005810-867C153D-2A0D-4138-9BA7-DED542E261E1

Q38005810-874BEFAF-6375-458B-AE88-4CA2055B73A2

Q38005810-BDBA5815-FDB2-45E1-940C-394129443BFF

P577

Q38005810-DF369AFF-DB60-429B-AD27-96B1D1736756

P5875

Q38005810-5615886F-76B3-4BA4-A7DD-9E551A005252

P698

Q38005810-A9469383-B53E-4F14-BCA1-05295120CF8B

P921

Q38005810-09229C19-C974-455A-B8CC-FA5ED0BCA38C

P932

Q38005810-1252A0DB-22D0-4C88-B343-245F0F43744E

P356

J.GASTRO.2012.04.032

P1433

Gastroenterology

P1476

Consensus statements for manag ...... ma, based on a Delphi process.

@en

P2093

Amitabh Chak

http://www.w3.org/2001/XMLSchema#string

Bill Allum

http://www.w3.org/2001/XMLSchema#string

Charles Gordon

http://www.w3.org/2001/XMLSchema#string

Chris Abley

http://www.w3.org/2001/XMLSchema#string

Chris Haigh

http://www.w3.org/2001/XMLSchema#string

David Al Dulaimi

http://www.w3.org/2001/XMLSchema#string

David Armstrong

http://www.w3.org/2001/XMLSchema#string

David Hewin

http://www.w3.org/2001/XMLSchema#string

David Johnston

http://www.w3.org/2001/XMLSchema#string

David Poller

http://www.w3.org/2001/XMLSchema#string

P2860

The Vienna classification of gastrointestinal epithelial neoplasia

Radiofrequency ablation in Barrett's esophagus with dysplasia

Endoscopic radiofrequency ablation for Barrett's esophagus: 5-year outcomes from a prospective multicenter trial

Local endoscopic therapy for intraepithelial high-grade neoplasia and early adenocarcinoma in Barrett's oesophagus: acute-phase and intermediate results of a new treatment approach.

A systematic review and meta-analysis of the treatment for Barrett's esophagus.

Molecular alterations of Barrett's esophagus on microdissected endoscopic biopsies.

5-aminolevulinic acid photodynamic therapy versus argon plasma coagulation for ablation of Barrett's oesophagus: a randomised trial

Endoscopic treatment of high-grade dysplasia and early stage cancer in Barrett's esophagus.

Circumferential endoscopic resection of Barrett's esophagus with high-grade dysplasia or early adenocarcinoma.

Five-year efficacy and safety of photodynamic therapy with Photofrin in Barrett's high-grade dysplasia.

P304

336-346

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1053/J.GASTRO.2012.04.032

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

143

http://www.w3.org/2001/XMLSchema#string

P50

Janusz A. Jankowski

Heike Irmgard Grabsch

Laurence B. Lovat

Gaius Longcroft-Wheaton

P577

2012-04-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

224853966

http://www.w3.org/2001/XMLSchema#string

P698

22537613

http://www.w3.org/2001/XMLSchema#string

P921

P932

5538857

http://www.w3.org/2001/XMLSchema#string